Tandem Diabetes Care, Inc. Amortization of Debt Issuance Costs
Tandem Diabetes Care, Inc. (TNDM) reported Amortization of Debt Issuance Costs of $1.38 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:AmortizationOfFinancingCosts · last filed 2026-08-06
- Tandem Diabetes Care, Inc. amortization of debt issuance costs for the quarter ending 2026-06-30 was $808.00K, a 73.76% increase year-over-year.
- Tandem Diabetes Care, Inc. amortization of debt issuance costs for the quarter ending 2026-03-31 was $576.00K, a 14.06% increase year-over-year.
- Tandem Diabetes Care, Inc. amortization of debt issuance costs for the quarter ending 2025-12-31 was $446.00K, a 11.16% decline year-over-year.
- Tandem Diabetes Care, Inc. amortization of debt issuance costs for the quarter ending 2025-09-30 was $444.00K, a 11.55% decline year-over-year.
- Tandem Diabetes Care, Inc. amortization of debt issuance costs for fiscal 2025 was $1.86M, a 10.96% decline from fiscal 2024.
- Tandem Diabetes Care, Inc. amortization of debt issuance costs for fiscal 2024 was $2.09M, a 5.22% decline from fiscal 2023.
- Tandem Diabetes Care, Inc. amortization of debt issuance costs for fiscal 2023 was $2.20M, a 16.24% increase from fiscal 2022.
- Tandem Diabetes Care, Inc. amortization of debt issuance costs for fiscal 2022 was $1.90M, a 9.79% increase from fiscal 2021.
| Period end | Amortization of Debt Issuance Costs 3 month | Amortization of Debt Issuance Costs 6 month | Amortization of Debt Issuance Costs 9 month | Amortization of Debt Issuance Costs 12 month |
|---|---|---|---|---|
| 2026-06-30 | $808.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $1.38M 10-Q · filed 2026-08-06 | $1.83M derived: sum of 3 quarters · filed 2026-08-06 | $2.27M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $576.00K 10-Q · filed 2026-05-07 | $1.02M derived: sum of 2 quarters · filed 2026-05-07 | $1.47M derived: sum of 3 quarters · filed 2026-05-07 | $1.93M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | $446.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $890.00K derived: sum of 2 quarters · filed 2026-02-19 | $1.35M derived: sum of 3 quarters · filed 2026-08-06 | $1.86M 10-K · filed 2026-02-19 |
| 2025-09-30 | $444.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $909.00K derived: sum of 2 quarters · filed 2026-08-06 | $1.41M 10-Q · filed 2025-11-06 | $1.92M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $465.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $970.00K 10-Q · filed 2026-08-06 | $1.47M derived: sum of 3 quarters · filed 2026-08-06 | $1.97M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $505.00K 10-Q · filed 2026-05-07 | $1.01M derived: sum of 2 quarters · filed 2026-05-07 | $1.51M derived: sum of 3 quarters · filed 2026-05-07 | $1.94M derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | $502.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $1.00M derived: sum of 2 quarters · filed 2026-02-19 | $1.44M derived: sum of 3 quarters · filed 2026-02-19 | $2.09M 10-K · filed 2026-02-19 |
| 2024-09-30 | $502.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $937.00K derived: sum of 2 quarters · filed 2025-11-06 | $1.59M 10-Q · filed 2025-11-06 | $2.08M derived: sum of 4 quarters · filed 2026-02-19 |
| 2024-06-30 | $435.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06 | $1.08M 10-Q · filed 2025-08-06 | $1.58M derived: sum of 3 quarters · filed 2026-02-19 | $2.28M derived: sum of 4 quarters · filed 2026-02-19 |
| 2024-03-31 | $650.00K 10-Q · filed 2025-04-30 | $1.14M derived: sum of 2 quarters · filed 2026-02-19 | $1.84M derived: sum of 3 quarters · filed 2026-02-19 | $2.35M derived: sum of 4 quarters · filed 2026-02-19 |
| 2023-12-31 | $493.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $1.20M derived: sum of 2 quarters · filed 2026-02-19 | $1.70M derived: sum of 3 quarters · filed 2026-02-19 | $2.20M 10-K · filed 2026-02-19 |
| 2023-09-30 | $702.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-06 | $1.21M derived: sum of 2 quarters · filed 2024-11-06 | $1.71M 10-Q · filed 2024-11-06 | $2.21M derived: sum of 4 quarters · filed 2025-02-26 |
| 2023-06-30 | $506.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-01 | $1.01M 10-Q · filed 2024-08-01 | $1.51M derived: sum of 3 quarters · filed 2025-02-26 | $2.01M derived: sum of 4 quarters · filed 2025-02-26 |
| 2023-03-31 | $503.00K 10-Q · filed 2024-05-02 | $1.00M derived: sum of 2 quarters · filed 2025-02-26 | $1.50M derived: sum of 3 quarters · filed 2025-02-26 | $1.96M derived: sum of 4 quarters · filed 2025-02-26 |
| 2022-12-31 | $501.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-26 | $1.00M derived: sum of 2 quarters · filed 2025-02-26 | $1.46M derived: sum of 3 quarters · filed 2025-02-26 | $1.90M 10-K · filed 2025-02-26 |
| 2022-09-30 | $499.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-01 | $957.00K derived: sum of 2 quarters · filed 2023-11-01 | $1.40M 10-Q · filed 2023-11-01 | |
| 2022-06-30 | $458.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | $896.00K 10-Q · filed 2023-08-03 | ||
| 2022-03-31 | $438.00K 10-Q · filed 2023-05-03 | |||
| 2021-12-31 | $1.73M 10-K · filed 2024-02-21 | |||
| 2021-03-31 | $428.00K 10-Q · filed 2021-05-05 | |||
| 2020-03-31 | $0.00 10-Q · filed 2021-05-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| Beta Bionics, Inc. (BBNX) | United States | $0.979B | -9.66 |
| SpyGlass Pharma, Inc. (SGP) | United States | $0.925B | |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |
| ANGIODYNAMICS INC (ANGO) | United States | $0.632B | -13.02 |
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B |